Showing results (351-360 of 369) with videos related to

Sort By:
Pageof 37
Ebiomedicine|May 7, 2023
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialTian-Tian Li, Bo Zhang, Hui Fang, et al.
Clinical and Molecular Hepatology|January 22, 2025
Update on the treatment navigation for functional cure of chronic hepatitis B: Expert consensus 2.0Di Wu, Jia-Horng Kao, Teerha Piratvisuth, et al.
Ebiomedicine|June 29, 2026
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infectionYou-Yuan Wang, Jun-Liang Fu, Wen-Xin Wang, et al.
Hepatology International|September 15, 2022
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureHua-Jie Li, Ning Yang, Xiuying Mu, et al.
Communications Biology|July 7, 2023
Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapyYou-Yuan Wang, Cheng Zhen, Wei Hu, et al.
Signal Transduction and Targeted Therapy|February 11, 2021
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trialLei Shi, Hai Huang, Xuechun Lu, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|December 15, 2020
Efficacy and safety of elbasvir/grazoprevir in treatment-naive Chinese adults with hepatitis C virus infection: A randomized trialLai Wei, Ji Dong Jia, Zhong Ping Duan, et al.
Medcomm|July 17, 2024
Detection of minimal hepatic encephalopathy in patients with cirrhosis based on the Stroop-CN model (NCRCID-CHESS 2106): a prospective multicenter studyXiaoyan Li, Shanghao Liu, Ying Guo, et al.
Eclinicalmedicine|April 15, 2024
Efficacy and safety of GST-HG171 in adult patients with mild to moderate COVID-19: a randomised, double-blind, placebo-controlled phase 2/3 trialHongzhou Lu, George Zhang, John Mao, et al.
Infectious Diseases of Poverty|November 26, 2020
Increased circulating level of interleukin-6 and CD8+ T cell exhaustion are associated with progression of COVID-19Peng-Hui Yang, Yi-Bo Ding, Zhe Xu, et al.
Pageof 37